The database included 5,780 initial patient encounters with spine surgeons at UCSF and 281 instances of readmission within 30 days.
However, 69 of the readmissions were second stage planned surgeries or were unrelated to spinal surgery. In 14 cases, patients returned because their surgery was cancelled and rescheduled electively. In 39 cases, the readmission was actually a planned, second stage surgery, such as ALIF after a posterior lumbar scoliosis surgery. There were 16 cases where patients returned to the hospital for reasons unrelated to the index spine surgery, such as a twisted ankle after lumbar disc surgery.
After calculating these differences, the researchers found the costs of hospital readmissions attributed to the spine surgeons dropped 29 percent, reflecting a $3 million cost variance. There are proposals to financially penalize hospitals for such readmissions.
Praveen Mummaneni, MD, co-author of the study discusses their findings and what implications the report will have in the future.
Q: What impact does this research have for spine surgeons?
Dr. Praveen Mummaneni: This study was really eye-opening because we found that 29 percent of what we considered to be reasonably related readmissions were not related to the index spine surgery. Such administrative data reports should exclude planned second stage surgeries (i.e a staged alif for patients undergoing surgery for scoliosis) and cases where the readmissions were unrelated to spine surgery. For example, if someone had surgery on their spine and then later tripped and twisted their ankle and came back for orthopedic services, that was counted as a readmission. The automated report would say it was a readmission attributed to the spine surgeon when really it was not.
There were multiple instances like that and when readmission rates will count against us that will be a problem. If payors (insurance companies or Medicare) withheld payments for the 29 percent of our readmissions that shouldn't have been counted in the first place, it would have been at a $3 million cost to the University. We were astounded by that.
Q: What should be done to fix this issue?
PM: We shared this information with the United HealthSystem Consortium (UHC), the member organization of over 95 percent of non-profit academic medical centers and asked if planned admissions can be identified so that these cases would not count against the surgeon. I think there is something that can be done with the algorithm to correct this overestimation of relevant readmissions, and surgeons need to get involved and reexamine the reported rates at their hospitals.
We sat down with UHC and they also have concerns with using all cause readmission rates without the ability to drilldown to the cases. They note the flexibility of their database to sort readmissions by numerous variables including principle diagnosis and procedure. The UHC CDB Report Builder allows drilldown ability to the case level. They are trying to work with us to add a planned readmission field to the data feed for the hospital to submit with the data to help hospitals sort planned readmissions. UHC continues to work with its members to make its tools actionable to drive process improvement to deliver optimal patient care.
Q: How do these numbers impact national benchmarks?
PM: If you are trying to benchmark yourself against a national readmissions number that isn't realistic, that isn't a fair benchmark. Surgeons can look at our article, which will come out next month in the Journal of Neurosurgery: Spine, and identify our top four reasons for inappropriate readmissions and then compare them with their institutions. I think they will capture most of the unnecessary readmissions if they look at our top four unrelated categories.
Using readmissions as a benchmarking metric will be more fair once the algorithm has been adjusted and validated with the correct filters.
Q: Are payors taking these numbers into account? How will coverage be impacted in the future?
PM: I think the payors have to take into account that not every readmission is preventable and surgeons are not able to prevent many readmissions.
If they don't take that into account, they aren't working with reality. There are some things that are not preventable and some things that are. It's going to be devastating if they don't pay for readmissions that are not related to spine surgery. It would inhibit patient care. You can't provide a high level of care and lose money on the second admission — it's not financially viable for hospitals and physicians. That's going to become a patient access issue for those needing complex spine care.
More Articles on Spinal Surgery:
8 Steps to Optimize Spine Practice Revenue in 2013
50 Spine Surgeons Focusing on Scoliosis Development
16 Spine Devices Receive FDA 510(k) Clearance in November
A 2nd Look at Spine Surgery Readmissions to Prevent a $3M Loss: Q&A With Dr. Praveen Mummaneni of UCSF FeaturedWritten by Laura Dyrda | Thursday, 20 December 2012 18:46
Surgeons and researchers at the University of California, San Francisco recently extracted data on hospital readmissions following spine surgery at UCSF to determine the reason for the readmissions. They found the number of readmissions attributed to the spine surgeons was significantly larger than the surgeons found appropriate because the "all-cause readmission algorithm" inappropriately included patients who were readmitted for planned second stage surgeries as well as patients who returned to the hospital for issues unrelated to their spinal procedure.Last modified on Friday, 04 January 2013 15:19
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies here.
Most Read - Spine
- Oregon spine surgeon implicated in $22M lawsuit for paralyzing patient with dropped instrument: 5 things to know
- UCLA pays $8.5M to settle 2 lawsuits after undisclosed spine surgeon relationship with Medtronic: 5 key notes
- The state of minimally invasive spine surgery: Dr. Frank Phillips on devices, payment & outpatient ASCs
- Do you know what patients really care about when choosing a spine surgeon?
- The role of the surgical microscope in modern MIS spine — Drs. K.D. Riew, Michael Mayer, Roger Härtl & Mohd Hisam Muhamad Ariffin share their experiences
Top 40 Articles from the Past 6 Months
- 22 spine surgeon leadership awards | 2016
- Has Xenco Medical Ushered in the Future of Spine Surgery?
- Zimmer Biomet, Stryker, J&J & more: 26 key notes — AAOS edition
- Dr. James Andrews #5 among richest doctors in the world: 6 points
- Beyond the device: How DePuy Synthes is innovating in orthopedic & spine technology
- Orthopedic surgeons generate $2.7M for affiliated hospitals; 5.5 times what they make — 5 survey findings
- Dr. Kevin Pauza unsurprised with Tiger Woods' slow back surgery recovery: 5 insights
- CJR bundles to pay $25k per episode: 8 statistics on cost breakdown
- Top 10 highest-earning physician specialties — Orthopedics leads for 6th consecutive year
- Novel technologies make a splash in outpatient spine setting — Dr. Nick Shamie weighs in
- PODs under attack again: 5 key notes from the Senate Finance Committee's report
- Where global spine market leaders are headed: 7 key notes on Medtronic, DePuy Synthes, Stryker & more
- 6 statistics on orthopedic surgeon compensation — Which practice setting pays most?
- 21 smart spine surgeons with gifted business minds
- CMS's lowest vs. highest-paid physicians: 5 key points
- Consumer Reports: 34 top-rated US hospitals for hip replacements
- Top 12 most-liked spine surgeons on the internet
- Dr. George Rappard performs 1st US MIS procedure with Sony heads-up display: 5 observations
- Siemens, Ziehm, GE, Hologic, OrthoScan & Medtronic: 26 O-arm & C-arm systems
- Which 4 emerging trends will drive the global spine surgery market?
- Orthopedic surgeons leave Salina Regional over on-call payment dispute: 5 things to know
- Andrews Institute adds regenerative medicine, stem cell center: 5 things to know
- Annual & hourly orthopedic surgeon salary — 10 latest statistics
- ISSCR updates stem cell research guidelines; warns against stem cell medical tourism — 5 insights
- The low hanging fruit of HIPAA compliance: 8 best practices
- Zimmer Biomet to acquire LDR in $1B transaction — 9 things to know
- The great PA debate: Should spine surgeons hire them?
- Surgeon entrepreneur: Dr. Kern Singh's quest to make lateral spine surgery more accessible
- Trusting a robot — Dr. Juan Torres-Reveron on performing 1st US ROSA Spine surgery
- MIS spine's promising future — Key insights from SMISS President Dr. Greg Anderson
- 87% of solo practitioners to face MIPS penalty in 2019 — 6 statistics on how Medicare's new payment model may impact solo physicians & small practices
- How Responsive Orthopedics defied the industry norm to make knee, hip devices more affordable — 6 key insights
- Paradigm Spine pays $585k in False Claims Act settlement; denies allegations: 5 things to know
- 12 statistics on social media's presence in the healthcare space
- 5 key notes on the Zimmer Biomet-LDR acquisition & its impact on Texas
- UPMC to pay $2.5M+ to settle neurosurgery-related False Claims Act violation allegations: 7 things to know
- Bundled payments to account for 30%-45% of spine reimbursement in 3 years: 4 insights
- More than half of hospital orthopedic programs unprepared for CMS joint replacement program: 7 takeaways
- 5 key points on Midwest Orthopaedics at Rush's bundled payments making healthcare affordable & transparent
- US News & World Report: Top 10 hospitals for orthopedics